| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $385.7M | +42.5% |
| R&D Expense | $187.1M | +91.0% |
| SG&A Expense | $411.4M | +27.3% |
| Operating Income | -$280.6M | -21.0% |
| Interest Expense | -$21.6M | -7.7% |
| Pre-tax Income | -$287.1M | -20.5% |
| Income Tax | $85K | -91.1% |
| Net Income | -$287.2M | -20.1% |
| EPS (Basic) | -$5.99 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $315.4M | -18.3% |
| Accounts Receivable | $142.0M | +49.8% |
| Inventory | $15.7M | +3.9% |
| Current Assets | $485.1M | -3.8% |
| Total Assets | $568.5M | -3.4% |
| Current Liabilities | $230.1M | +65.7% |
| Long-term Debt | $180.7M | +1.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$128.4M | +11.5% |
| Capital Expenditures | $270K | -53.6% |
| Investing Cash Flow | -$270K | +53.6% |
| Financing Cash Flow | $57.8M | -82.5% |
| Free Cash Flow | -$128.7M | +11.7% |
| -13.7% |
| EPS (Diluted) | -$5.99 | -13.7% |
| Total Liabilities |
| $511.5M |
| +28.8% |
| Stockholders' Equity | $57.0M | -70.1% |